Andere Sprachen Bliss GVS Pharma Limited

Aktien

A2H9VK

INE416D01022

BLISSGVS

Markt geschlossen - Bombay S.E. Andere Börsenplätze 12:28:38 24.05.2024			% 5 Tage	% 1. Jan.
106,9 ^INR	-0,23 %		-2,06 %	-14,21 %

02.05.	Bliss GVS Pharma Limited berichtet über die Ergebnisse für das Geschäftsjahr zum 31. März 2024	CI
02.05.	Bliss GVS Pharma Limited meldet die Ergebnisse für das vierte Quartal bis zum 31. März 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Bliss GVS Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024	02.05.
Bliss GVS Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	02.05.
Bliss GVS Pharma Limited Recommends Final Dividend for the Financial Year Ended March 31, 2024	02.05.
Bliss GVS Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	23.01.
Bliss GVS Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	01.11.
Assistant Commission of State Tax Maharashtra, Mumbai Initiates Search At Certain Premises of Bliss GVS Pharma Limited	07.09.23
Bliss Gvs Pharma Limited Announces Change in the Designation of Mr. Vishal Vijay Rao	01.08.23
Bliss GVS Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	01.08.23
Bliss GVS Pharma Limited Declares Final Dividend for the Financial Year Ended March 31, 2023	19.07.23
Bliss GVS Pharma Gets Establishment Inspection Report from US FDA for Palghar, India Unit	15.06.23
Bliss Gvs Pharma Limited Recommends Final Dividend for the Financial Year Ended March 31, 2023	11.05.23
Bliss GVS Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	11.05.23
Bliss GVS Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2023	11.05.23
Infomerics Keeps BBB Rating on Bliss GVS Pharma's Bank Financing; Outlook Stable	10.04.23
Bliss GVS Pharma Gets Three Observations from US FDA's Plant Inspection in Maharashtra, India	20.03.23
Bliss GVS Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	24.01.23
Bliss GVS Pharma Names New CFO	30.12.22
Bliss GVS Pharma Limited Appoints Mr. Deepak Sawant as Chief Financial Officer	30.12.22
Bliss GVS Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	07.11.22
Bliss GVS Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	03.08.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Bliss GVS Pharma Limited

Aktien

A2H9VK

INE416D01022

BLISSGVS

Andere Sprachen

Filter